Vascular Endothelial Growth Factor and Angiogenesis

Authors:
  • BLBart Landuyt
    Bart Landuyt
  • MHMartin S. Highley
    Martin S. Highley
  • HWHans Wildiers
    Hans Wildiers
  • AOAllan T. Van Oosterom
    Allan T. Van Oosterom
  • EBErnst A. De Bruijn
    Ernst A. De Bruijn

Abstract
Angiogenesis is a hallmark of wound healing, the menstrual cycle, cancer, and various ischemic and inflammatory diseases. A rich variety of pro- and antiangiogenic molecules have already been discovered. Vascular endothelial growth factor (VEGF) is an interesting inducer of angiogenesis and lymphangiogenesis, because it is a highly specific mitogen for endothelial cells. Signal transduction involves binding to tyrosine kinase receptors and results in endothelial cell proliferation, migration, and new vessel formation. In this article, the role of VEGF in physiological and pathological processes is reviewed. We also discuss how modulation of VEGF expression creates new therapeutic possibilities and describe recent developments in this field.

This publication has 224 references indexed in Scilit: